OST31-164
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OST31-164, covering 2025-01-22 to 2025-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Osteosarcoma Maintenance Therapy With OST31-164 [Phase 2]